Cytori Therapeutics receives approval

China granted regulatory clearance to Cytori Therapeutics Inc.'s (Nasdaq: CYTX) exclusive licensee Lorem Vascular to market and sell the Cytori Celution System. The stock price climbed 16 cents to close at $1.32.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.